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Analysis of cell-associated DenV 
RNA by oligo(dT) primed 5’ capture 
scRnAseq
Mark A. Sanborn1, tao Li1, Kaitlin Victor1, Hayden Siegfried1, christian fung1, 
Alan L. Rothman2, Anon Srikiatkhachorn2,3, Stefan fernandez4, Damon ellison1, 
Richard G. Jarman1, Heather friberg1, irina Maljkovic Berry1, Jeffrey R. currier1 & 
Adam t. Waickman1 ✉
Dengue is one of the most widespread vector-borne viral diseases in the world. However, the size, 
heterogeneity, and temporal dynamics of the cell-associated viral reservoir during acute dengue virus 
(DENV) infection remains unclear. In this study, we analyzed cells infected in vitro with DENV and PBMC 
from an individual experiencing a natural DENV infection utilizing 5’ capture single cell RNA sequencing 
(scRNAseq). Both positive- and negative-sense DENV RNA was detected in reactions containing either 
an oligo(dT) primer alone, or in reactions supplemented with a DENV-specific primer. The addition of a 
DENV-specific primer did not increase the total amount of DENV RNA captured or the fraction of cells 
identified as containing DENV RNA. However, inclusion of a DENV-specific cDNA primer did increase 
the viral genome coverage immediately 5’ to the primer binding site. Furthermore, while the majority 
of intracellular DENV sequence captured in this analysis mapped to the 5’ end of the viral genome, 
distinct patterns of enhanced coverage within the DENV polyprotein coding region were observed. 
The 5’ capture scRNAseq analysis of PBMC not only recapitulated previously published reports by 
detecting virally infected memory and naïve B cells, but also identified cell-associated genomic variants 
not observed in contemporaneous serum samples. These results demonstrate that oligo(dT) primed 5’ 
capture scRNAseq can detect DENV RNA and quantify virus-infected cells in physiologically relevant 
conditions, and provides insight into viral sequence variability within infected cells.
Dengue is one of the most widespread vector-borne viral diseases in the tropical and sub-tropical regions of the 
world. The causative agent– dengue virus (DENV) – is a positive-stranded RNA virus maintained in an anthro-
ponotic cycle between the Aedes aegypti mosquito and humans1. Consisting of four co-circulating but genetically 
and immunologically distinct serotypes (DENV-1, −2, −3, and −4), DENV is thought to infect between 280 and 
550 million people worldwide every year2,3. Although the majority of DENV infections are subclinical, as many 
as 100 million infections every year result in symptomatic dengue fever. In addition, up to 500,000 infections per 
year result in severe dengue, which has a mortality rate of nearly 2.5%4–7.
Following introduction into a human host by an infected mosquito during a blood meal acquisition, DENV 
asymptomatically replicates for 3–14 days prior to the onset of viremia or any clinical manifestation of infection8. 
After a presumed initial round of replication at the site of infection within tissue-resident or tissue-transiting 
leukocytes, DENV has been thought to disseminate and replicate within phagocytic mononucleocytes such as 
dendritic cells, monocytes, and macrophages which express the surface receptors DC-SIGN and/or mannose 
receptor9–12. However, recent studies utilizing techniques such as flow cytometry, RNAseq, and quantitative 
RT-PCR have demonstrated that B cells represent the major circulating cellular reservoir of DENV in individuals 
experiencing a natural DENV infection13–15. In any case, quantifying the cell-associated viral burden of DENV 
has the potential to provide actionable information in the setting of acute dengue, as differences in the cellular 
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tropism/burden of DENV has been demonstrated in at least one report to correlate with the clinical severity of 
infection and with previous dengue exposure13.
Recent advances in single cell RNA sequencing (scRNAseq) technology have revolutionized the field of cellu-
lar biology, providing insight into the heterogeneity of cellular transcription in an unbiased yet high-resolution 
fashion16. scRNAseq has also been leveraged to quantify the cellular tropism of several RNA viruses including 
influenza17,18, West Nile19, Zika20, and DENV20,21. The majority of these published reports utilized a variant of the 
Smart-seq2 scRNAseq technology, wherein individual cells are deposited into separate wells in a 96 or 384 well 
plate containing the necessary reagents for cDNA synthesis and mRNA barcoding22. In addition to an oligo(dT) 
primer used to capture mammalian mRNA, these studies utilize a custom pathogen-specific primer during the 
cDNA synthesis reaction to maximize viral RNA recovery20,21. While the published DENV-targeted Smart-seq2 
methodology for DENV has demonstrated the potential to provide full-length viral sequence information, there 
are several limitations to the approach that may impede its broader adoption. Firstly, the targeted Smart-seq2 
approach is low-throughput and relatively labor intensive even with modern fluid-handling robotics. Secondly, 
relying on a targeted primer for the detection and quantification of DENV RNA leaves open the possibility that 
divergent viral species will not be sufficiently primed to allow for downstream quantification.
An alternative to the commonly used Smart-seq2 scRNAseq methodology is 5′ capture scRNAseq, wherein 
only the 5′ end of a transcript is captured in the final sequencing library and tagged in such a manner to allow for 
cell-specific deconvolution16,23. While this approach theoretically only captures the 5′ end of any transcript primed 
by the proffered cDNA synthesis primer (conventionally an oligo(dT) primer), it has the significant advantage of 
being compatible with several massively-parallel microfluidics-based platforms that allow for the simultaneous 
analysis of thousands of cells in a single reaction16. Although 5’ capture technology does not theoretically afford 
the same transcript coverage as other techniques, the total transcript recovery and unique gene recovery rate per 
cell is comparable with other technologies, and the exponentially greater number of cells analyzed allows for an 
unparalleled level of population resolution16,23. Therefore, given the theoretical advantages offered by a 5’ capture 
approach, we attempted to determine if the technology is compatible with cell-associated DENV detection and 
quantification in the presence or absence of a virus-specific cDNA synthesis primer.
In this study, we first analyzed cells infected in vitro with DENV-1 utilizing 5′ capture scRNAseq. Despite 
the absence of a canonical polyadenylated tail, DENV RNA was incorporated in the 5′ capture scRNAseq reac-
tions containing only an oligo(dT) primer, as well as in reactions supplemented with a DENV-specific primer. 
The addition of a DENV-specific cDNA synthesis primer did not appreciably increase either the total amount 
of DENV RNA captured by 5′ capture scRNAseq analysis or the fraction of cells flagged as containing DENV 
RNA. The only effect observed upon the addition of a DENV-specific primer was an increase in the viral genome 
coverage proximal to the primer binding site. The majority of the DENV sequences recovered aligned to the 5′ 
end of the viral genome, but a regular pattern of higher-density coverage was noted across all in vitro infection 
samples. We then verified that 5′ capture scRNAseq can be utilized to detect/quantify cell-associated DENV 
RNA in PBMC from an individual experiencing a natural secondary DENV-1 infection. This analysis recapitu-
lated previous reports of DENV-infected B cells and identified cell-associated viral variants that were not present 
in contemporaneous serum samples. These results demonstrate for the first time that DENV can be detected 
and quantified in physiologically relevant conditions using oligo(dT) primed 5′ capture scRNAseq, and provides 
insight into sequence variability of the DENV genome contained within infected cells.
Results
Detection of DENV RNA by 5’ capture scRNAseq. To test the feasibility of quantifying intracellular 
DENV RNA in a 5′ capture scRNAseq assay - and the necessity for a DENV-specific primer in the RT reac-
tion – we first utilized an in vitro cell infection model (Fig. 1A). A DC- SIGN (CD209) expressing CEM.NKR 
cell line (NKR2001A) was infected with DENV-1 (strain Nauru/West Pac/1974) at a MOI of 1 and cultured 
for 18 hours prior to harvest and analysis. Surface DENV-1 NS1 expression was assessed to confirm productive 
infection, and NS1p°s cells were sorted from the DENV-1 infected culture (Fig. 1B). The uninfected parental CEM.
NKR.DC-SIGN cell line, the bulk DENV-1 infected culture, and the sorted DENV-1 infected NS1pos population 
were all subjected to scRNAseq 5’ capture analysis using a standard oligo(dT) RT primer for cDNA synthesis 
(Supplemental Fig. 1). In addition, a parallel scRNAseq 5’ capture assay was performed on the sorted DENV-1 
infected NS1pos population where a DENV-specific primer was added in addition to the conventional oligo(dT) 
primer at a 1:100 ratio (Supplemental Fig. 1). Illumina-compatible NGS libraries were then generated from all 
samples, and sequenced to an equivalent depth on a NovaSeq 6000 instrument with a 2 × 150 bp paired-end (PE) 
read configuration. Samples were subsequently demultiplexed and aligned against the human GRCh38 or DENV-
1(NCBI Reference Sequence NC_001477.1) reference genomes.
An equivalent number of PE reads from all samples were confidently aligned and annotated against the human 
GRCh38 reference genome, indicating that neither DENV-1 infection nor the addition of the DENV-specific 
primer to the cDNA synthesis reaction significantly impacted the read depth/quality of the host genome-derived 
RNA sequence data (Fig. 1C, Table 1). In contrast, the number of PE reads confidently mapped against the 
DENV-1 reference genome varied significantly between the uninfected and DENV-infected samples, with the 
least number of reads identified in the uninfected samples (334 of 7.2 × 108 total PE reads), and the most in 
the sorted NS1pos DENV-1 infected sample (1.9 × 106 of 9.6 × 108 total PE reads). The number of reads con-
fidently mapped to the DENV-1 reference genome was additionally reflected in the fraction of captured cells 
flagged as containing > =1 transcript of DENV RNA (Fig. 1D). Approximately 70% of the cells from the bulk 
DENV infected culture were identified as harboring DENV RNA, while more than 98% of the cells in both of the 
sorted NS1pos DENV-1 infected samples were identified as containing DENV-1 RNA. These data demonstrate 
that DENV RNA can be detected using 5′ capture scRNAseq analysis, and that a DENV-specific primer is not 
necessary to obtain this result.
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Quantification of DENV RNA by 5’ capture scRNAseq. To better characterize the DENV RNA iden-
tified in our scRNAseq 5′ capture assay, we examined the abundance and length of each unique RNA template 
tagged with a unique molecular identifier (UMI) that mapped to the DENV-1 reference genome. The number 
Figure 1. 5′ capture scRNAseq analysis of in vitro DENV infected cells. (A) Schematic representation of 
the infection, isolation, and analysis strategy utilized in this study. (B) Surface DENV-1 NS1 expression on 
uninfected, DENV-1 infected, and sorted NS1pos DENV-1 infected DC-SIGN expressing CEM.NKR cells 
utilized for scRNAseq analysis. (C) Number of PE reads confidently mapped from each sample to either the 
Gh38 human genome assembly or the DENV-1 (strain WestPac74) genome from each sample (D) Fraction of 
cells from each sample with > =1 confidently mapped DENV-1 transcript present.
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of unique UMI-tagged DENV RNA molecules identified (DENV RNA-positive) per cell ranged between 1 and 
500 in all infected samples, with the sorted NS1pos populations containing on average 2X the number of DENV-1 
mapped UMIs as the unsorted DENV-1 infected sample (Fig. 2A). No significant increase in the number of 
UMIs/cell was observed within the sample containing the additional DENV specific primer. The length of the 
DENV-1 reads ranged between 100 and 600 bp, which is consistent with the library preparation strategy utilized 
during the assay (Fig. 2B). Correspondingly, on average each DENV-mapped UMI reflected ~3% of the DENV-1 
genome (Fig. 2C). When aligned in aggregate, the total DENV genome recovered per cell ranged between 3% 
and 99%, with the median genome recovery rate significantly higher in the sorted NS1pos DENV infected samples 
than in the bulk-infected sample (Fig. 2D). On average, 50% full-length DENV-1 genome coverage was achieved 
with 38.3 UMIs per cell across all infected samples, while 75% genome coverage was achieved with 100 UMIs 
Sample name

















Uninfected 364,378,131 84.7% 5,680 40,998 17,796
DENV-1 infected 436,057,561 84.7% 5,416 37,282 18,410
DENV-1 infected 
NS1pos 478,167,079 86.1% 5,530 40,664 18,719
DENV-1 infected 
NS1pos + DENV 
primer
443,086,874 88.7% 5,507 39,951 18,610
Table 1. Sequencing and annotation statistics for in vitro infection experiments.
Figure 2. Characteristics of DENV-1 mapped transcripts identified by 5′ capture scRNAseq. (A) Number of 
unique DENV-1 mapped transcripts identified per cell in DENV-1 infected DC-SIGN expressing CEM.NKR 
cell cultures (blue), DENV-1 infected sorted NS1pos cultures (red), and DENV-1 infected sorted NS1 pos cultures 
supplemented with a DENV-specific cDNA synthesis primer during scRNAseq analysis (orange). (B) DENV-1 
mapped insert lengths identified by scRNAseq analysis. (C) Median DENV-1 genome coverage obtained per 
UMI in 5′ capture scRNAseq analysis. (D) DENV-1 genome coverage achieved per cell by 5’ capture scRNAseq. 
Only cells with > =1 DENV-1 mapped UMIs are shown. (E) Relationship between DENV-1 UMI recovery and 
DENV-1 genome coverage achieved by 5′ capture scRNAseq. Curves calculated by non-linear regression (single 
variable). **** p < 0.0001, one-way ANOVA.
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per cell (Fig. 2E). Therefore, despite a single UMI providing a relatively small fragment of the DENV genome, a 
full-length cell-associated consensus genome can be constructed from relatively few unique transcripts.
Genomic coverage of positive-sense DENV generated by 5’ capture scRNAseq. Many cells cap-
tured in this analysis contained DENV RNA that confidently mapped across a significant fraction of the DENV-1 
genome. Therefore, we attempted to ascertain whether there were regions of preferential sequence recovery in our 
analysis or if the recovery was uniform across the DENV genome. We additionally attempted to determine if the 
inclusion of a DENV-specific RT primer altered the distribution of DENV genomic sequence recovery.
Consistent with the 5′ capture technology utilized in this analysis, ~27.5% to 32.0 of all positive-sense DENV-1 
reads aligned to the first 500 bp of the DENV genome in each sample (Figs. 3A–C). However, a consistent pattern 
of enriched positive-sense genomic sequence recovery was noted in all samples within the 3′ end of the polypro-
tein encoding region of the DENV genome (Fig. 3A–C). Inclusion of the DENV-specific primer increased the 
genomic coverage 300–500 bp upstream of the primer binding site (Fig. 3C).
Detection of negative-sense DENV RNA by 5’ capture scRNAseq. Productive DENV infection is 
accompanied by the generation of intracellular negative-sense DENV RNA24. As with other members of the 
virus family Flaviviridae, this intermediate antigenome is utilized as a template for the synthesis of additional 
positive-sense DENV genomic RNA25. In our analysis we observed that 67% of the unenriched DENV-1 infected 
CM.NKR cells analyzed by oligo(dT) primed scRNAseq simultaneously contained reads that mapped to either 
the positive- or negative-sense orientation of the DENV genome (herein referred to as positive- or negative-sense 
DENV RNA, respectively) (Fig. 4A). In contrast, 99% of sorted NS1pos cells – which by definition are produc-
tively infected – contained both positive- and negative-sense DENV RNA (Fig. 4A). Within DENV-infected cells, 
negative-sense DENV RNA accounted for ~7.1% of all annotated DENV RNA in both unfractionated and sorted 
NS1pos DENV-1 infected cells (Fig. 4B). A linear relationship was observed between the amount of positive-sense 
DENV RNA identified within a cell and the corresponding abundance of negative-sense RNA (Fig. 4C). However, 
the relatively low r2 value of these relationships (DENV-1 infected: 0.37. Sorted NS1pos DENV-1 infected: 0.25) 
suggests that factors other than the abundance of positive-sense DENV contributes to the relative abundance of 
negative-sense DENV RNA within DENV infected cells.
Enriched regions of negative-sense DENV RNA recovery was observed across the DENV genome in samples 
analyzed by 5′ capture scRNAseq (Fig. 4D). However, the pattern of negative-sense DENV RNA recovery is dis-
tinct from that observed for positive-sense DENV RNA in the same samples. These results demonstrate that 5’ 
capture scRNAseq can identify negative-sense DENV RNA within DENV infected cells, and that the frequency 
of cells harboring negative-sense DENV RNA corresponds with the presumed frequency of productive DENV 
infection.
Detection of DENV RNA in PBMC following natural infection by 5’ capture scRNAseq. To 
determine the feasibility of identifying and quantifying PBMC harboring DENV RNA following natural viral 
infection using 5′ capture scRNAseq, we analyzed PBMC samples obtained from an individual experiencing 
a natural secondary DENV-1 infection. To maximize the accuracy and sensitivity of the 5′ capture scRNAseq 
dependent detection of DENV genomic RNA, a custom DENV-1 reference was created using the sequence of the 
serum-associated virus infecting the individual in this study (Supplemental Fig. 3, Table 2). NGS analysis of the 
serum-associated DENV reservoir captured in this analysis provided a full-length genome with a coverage depth 
of 1000× or greater from both acute time points assessed in this study (fever day −2, fever day −1) (Table 2). A 
20% variant level analysis showed no genomic sequence variants at either time point within the serum-associated 
viral reservoir. However, a 1% variant level analysis showed 4 called synonymous variants at position 445 and 
9565 in the DENV polyprotein coding region that were present in equal frequencies at both time points (Table 2).
Two sequential PBMC samples were analyzed from this individual during the acute stage of infection (fever 
day −2, fever day −1), as well as a ‘baseline’ sample from 180 days post defervescence. Total viable CD3+ T cells 
and CD19+ B cells were sorted from the cryopreserved sample and analyzed by 5′ capture scRNAseq using an 
oligo(dT) primer for cDNA synthesis. A total of 9,565 cells were captured across all 3 time points, and 11 tran-
scriptionally distinct cell populations annotated using cell-associated transcripts confidently aligned against the 
GRCh38 reference genome (Fig. 5A, Supplemental Fig. 4, Supplemental Table 1). Cell-associated transcripts not 
mapped to the GrCh38 reference genome were subsequently aligned against a custom DENV-1 reference gener-
ated from the sequence of the serum-associated virus identified by targeted NGS sequencing (Supplemental Fig. 3, 
Table 2). Consistent with previously published reports, DENV-1 transcripts were identified within the peripheral 
B cell compartment in both naïve and memory-phenotype B cells (Fig. 5B,C). Both positive- and negative-sense 
DENV RNA was identified within the cells, indicating that they were productively infected (Supplemental Fig. 5). 
Although the total amount of DENV RNA recovered in this assay was insufficient to provide a full-length genome 
in any individual cell (Fig. 5D,E), in aggregate there was enough cell-associated DENV genomic material to gen-
erate a consensus genome sequence across both acute infection time points (Fig. 5F, Table 2).
Consistent with the coverage results obtained from the in vitro infection experiments, the majority of the con-
fidently mapped DENV-1 reads came from the first 500 bp of the DENV-1 genome (Fever day −2: 50.73%. Fever 
day −1: 53.3%). Although the cell-associated DENV genome sequencing depth was limited in this analysis, the 
synonymous genomic variants observed at position 445 within the serum-associated viral reservoir were also 
observed within the cell-associated viral reservoir at a nearly identical frequency at both time points analyzed 
(Table 2). In addition, a further 16 variants at 8 genomic positions were observed within the cell-associated 
viral reservoir that were not observed within the contemporaneous serum-associated viral reservoirs (Table 2). 
While the intracellular DENV sequence depth is limited in this analysis, these results suggest a greater degree 
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of genomic variation within the cell-associated DENV viral reservoir during acute DENV infection than in the 
serum-associated viral reservoir.
Discussion
In this study we demonstrate that DENV genomic RNA can be captured and quantified by 5′ capture scRNAseq. 
Despite the absence of a conventional polyadenylated 3′ tail, DENV genomic RNA was successfully captured 
utilizing an oligo(dT) primer without addition of a DENV-specific RT primer. The addition of a DENV-specific 
primer during the cDNA synthesis step did not appreciably increase the number of DENV RNA molecules 
Figure 3. Genome coverage of positive-sense DENV-1 mapped transcripts identified by 5′ capture scRNAseq. 
(A) Heatmap representation of positive-sense DENV-1 genomic sequence recovery in individual cells analyzed 
by 5′ capture scRNAseq from DENV-1 infected cultures (blue), DENV-1 infected sorted NS1pos cultures (red), 
and DENV-1 infected sorted NS1pos cultures supplemented with a DENV-specific cDNA synthesis primer 
(orange). Color intensity indicates sequence coverage/depth at that genomic location, vertical axis contains 
a single cell per line. Cells are ranked by total DENV-1 genomic coverage. Cells with > =1 DENV-1 mapped 
UMI are included in the visualization. (B) Positive-sense DENV-1 genomic localization of individual UMIs 
obtained from the top 10 cells in each analysis condition with the most DENV-1 coverage as assessed by 5′ 
capture scRNAseq analysis. UMIs are ranked by genomic location 5′ to 3′, and the vertical axis contains a single 
DENV-1 mapped UMI per line. (C) Aggregated positive-sense DENV-1 genomic coverage and sequence depth 
of all in vitro infected samples as assessed by 5′ capture scRNAseq.
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Figure 4. Characterization of negative-sense DENV RNA by 5′ capture scRNAseq (A) Fraction of indicated cell 
populations containing either only positive-sense DENV RNA (black), both positive- and negative-sense DENV 
RNA (gray), or only negative-sense DENV RNA (white) as quantified by 5′ capture scRNAseq. (B) Percentage of 
all DENV-mapped RNA with a negative-sense orientation in DENV-1 infected (blue) or sorted NS1pos DENV-1 
infected cells as quantified by 5′ capture scRNAseq. (C) Relationship between positive-sense and negative-
sense DENV RNA abundance within DENV-1 infected cells. (D) Aggregated negative-sense DENV-1 genomic 
coverage and sequence depth of in vitro infected samples as assessed by 5′ capture scRNAseq.
Fever Day -2 Fever Day −1
Genome 
Position










































92 C [H] > 1,000 C [H] 55




81 T [L] > 1,000 T [L] 14




50 G [G] > 1,000 G [G] 17














156 G [R] > 1,000 G [R] 24




79 C [L] > 1,000 C [L] 24













> 1,000 C [C] 19
Table 2. Cell and serum associated DENV sequence variation. nt – nucleotide, AA- amino acid.
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captured by 5′ scRNAseq analysis. The majority of the DENV sequences recovered in this analysis aligned to the 
5′ end of the viral genome, but a regular pattern of higher-density coverage was noted across all in vitro infection 
samples as well. As sequence recovery corresponds to locations where cDNA synthesis terminates in 5′ capture 
scRNAseq, this pattern may reflect unappreciated secondary structures in the native intracellular DENV genome 
that impeded the reverse transcriptase processivity. We additionally verified that 5′ capture scRNAseq can be uti-
lized to detect/quantify physiologically-relevant levels of cell-associated DENV RNA by analyzing samples from 
an individual experiencing a natural secondary DENV-1 infection. This analysis recapitulated previous reports 
by detecting virally infected B cells, and, in addition, we were able to compare the sequences of the cell-associated 
and serum viruses in the same individual. While both cell-associated and serum viruses possessed an identical 
intra-host single-nucleotide variant (iSNV) with approximately equal frequencies in one of the genomic posi-
tions, additional iSNVs were observed within the cell-associated viral reservoir that were not observed within the 
contemporaneous serum. While it has been established that DENV exists as a population of viral variants within 
a host26, these data reemphasize that these viral populations are similar, though not identical, in composition and 
frequency within these two different host compartments. Virus population compartmentalization has been well 
described in HIV27, and has been associated with disease severity. Whereas the chronic nature of HIV infection is 
in stark contrast to DENV, more studies are needed to determine if population compartmentalization and heter-
ogeneity has any relationship to dengue severity.
The observation that DENV genomic RNA is captured in a reverse transcription reaction utilizing 
anchored-oligo(dT) priming was initially unexpected but is not without precedent. Previous studies have demon-
strated that cDNA can be generated from flavivirus genomic RNA templates using an oligo(dT) primer, although 
the exact oligo(dT) primer binding sites were not resolved28. Furthermore, the anchored-oligo(dT) primer used 
in this analysis contains a degenerate 3′ terminus, which may increase the likelihood of the oligo binding/priming 
off a sequence other than a canonical mRNA poly-A tail. Indeed, internal transcript priming at A rich regions is 
a long-appreciated problem with oligo(dT) based RT-methods29–33. However, while it is plausible – even prob-
able - that the oligo(dT) primer used in the analysis presented here bound to polypyrimidine tracts within the 
DENV genome, the exact location of these internal priming events cannot be determined using this approach. 
This is due to the fact that the 5′ capture assay used in this study preferentially captures sequences from regions of 
RT-termination, rather than RT-initiation16,23.
While the location of RT initiation cannot be resolved by 5′ scRNAseq, this approach may unexpectedly allow 
for the resolution of native secondary/tertiary structures within the intracellular DENV genome. Extensive sec-
ondary structures within an RNA template can severely impede the processivity of a reverse transcriptase, lead-
ing to the production of truncated cDNA molecules downstream of the initial priming event34,35. This inherent 
feature of RT-dependent cDNA synthesis may be exacerbated by the fact that the MMLV-derived RT used in this 
5′ capture assay displays maximal enzymatic activity at 43 °C: a temperature at which significant secondary struc-
tures will be retained in single-stranded RNA templates. The observation that the inclusion of a DENV-specific 
RT primer only increases the depth of the recovered DENV genome at 200–500 bp downstream of the primer 
binding site reinforces the concept that RT processivity overall is profoundly limited on the DENV genome in 
the described scRNAseq assay. Therefore, if RT processivity is indeed limited on the DENV genome in this assay, 
oligo(dT) priming must occur frequently in order to achieve the levels of full genome coverage observed in our 
analysis.
While secondary structures within the 5′ and 3′ UTRs of the DENV genome are critical for viral replication, 
propagation, and genomic stability36–39, up to one-third of the nucleotides in the DENV genome have been sug-
gested to be involved in the formation of higher-order structures40. Conserved regions of secondary structure 
within the 5′ protein coding regions of the DENV-2 genome are known to play a role in regulating the translation 
of the DENV polyprotein41, while hairpin structures in the capsid region of multiple flaviviruses are critical for 
the initiation of viral RNA synthesis42,43. While significant secondary/tertiary structural features have been pre-
dicted to exist within the 3’ region of the DENV polyprotein-coding RNA sequence40, the prevalence and biolog-
ical role of these higher-order structures in vivo are currently unknown.
The ability to leverage massively parallel scRNAseq methods for the assessment of DENV cellular tropism 
represents an important technical advancement. By facilitating higher-resolution analysis of the cellular tropism, 
infection kinetics, and transcriptional consequences associated with DENV infection, this methodology may 
enable the identification of more accurate correlates of risk during acute DENV infection and potentially improve 
diagnostic accuracy.
Materials and Methods
cell lines. The parental CEM.NKR cell line was obtained through the NIH AIDS Reagent Program, Division 
of AIDS, NIAID, NIH, courtesy of Dr. Peter Cresswell44. A stably transfected and cloned, DC-SIGN (CD209: 
Genbank NM_021155) expressing variant of this cell line (NKR2001A) was developed for DENV-infection 
experiments.
Viruses. DENV-1 (strain Nauru/West Pac/1974) was propagated in C6/36 mosquito cells and was utilized for 
in vitro infection assays. Virus was concentrated by ultracentrifugation through a 30% sucrose solution and the 
virus pellet was resuspended in PBS.
Sample collection. Peripheral blood mononuclear cells (PBMC) were isolated from whole blood samples 
collected from children enrolled in a hospital-based acute illness study in Bangkok, Thailand45,46. The study 
included children who presented to the hospital with suspected dengue. Blood draws were obtained serially dur-
ing acute infection and at early and late convalescent time points; the term ‘fever day’ is used to report acute 
illness time points relative to Day 0, defined as the day of defervescence. The infecting virus type (DENV-1–4) 
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Figure 5. Identification and quantification of virally infected PBMC following natural DENV infection. (A) 
UMAP projection and population level-annotation of 9,565 sorted CD3+ and CD19+ PBMC analyzed by 5′ 
capture scRNAseq. Plot is an aggregated analysis of 3 timepoints from the same DENV-1 infected individual 
(fever days −2, −1, +180). (B) UMAP projection of sorted PBMCs captured by 5′capture scRNAseq indicating 
uninfected cells (blue) and cells containing > =1 DENV-1 mapped UMI (red). (C) Proportion of the identified 
PBMC populations from each analyzed time point containing > =1 UMI confidently mapped to the DENV-1 
genome. (D) Heatmap representation of DENV-1 genomic sequence recovery in individual cells analyzed by 
5′ capture scRNAseq from the fever day −2 PBMC sample. Infected cells are binned by population identity. 
(E) Heatmap representation of DENV-1 genomic sequence recovery in individual cells analyzed by 5′ capture 
scRNAseq from the fever day -1 PBMC sample. Infected cells are binned by population identity. (F) Aggregated 
DENV-1 genomic coverage and sequence depth of all in vivo infected samples as assessed by 5′ capture 
scRNAseq.
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was determined by virus isolation and/or RT-PCR47, and serology (EIA and HAI assays) was used to distinguish 
primary and secondary DENV infections48. Written informed consent was obtained from each subject and/or his/
her parent or guardian. The study protocol was approved by the Institutional Review Boards of the Thai Ministry 
of Public Health, the Office of the U.S. Army Surgeon General, the University of Rhode Island, and the University 
of Massachusetts Medical School. PBMC and plasma samples were cryopreserved for later analysis. All research 
was performed in accordance with relevant guidelines and regulations.
Flow cytometry and cell sorting. Cryopreserved PBMC were thawed and placed in RPMI 1640 medium 
supplemented with 10% FBS(Sigma), L-glutamine, penicillin, and streptomycin prior to analysis. Cell viability was 
assessed using CTL-LDC Dye (Cellular Tecnology Limited [CTL], Shaker Heights, OH) and a CTL-ImmunoSpot 
S6 Ultimate-V Analyzer (CTL). Surface staining for flow cytometry analysis and cell sorting was performed in 
PBS supplemented with 2% FBS at room temperature. Aqua Live/Dead (ThermoFisher, L34957) was used to 
exclude dead cells in all experiments. Antibodies and dilutions used for flow cytometry analysis are listed in 
Supplemental Table 2. Cell sorting was performed on a BD FACSAria Fusion instrument, and data analyzed using 
FlowJo v10.2 software (Treestar, https://www.flowjo.com).
Single-cell RNA sequencing library generation. Flow-sorted viable B and T cell suspensions or 
DC-SIGN expressing CEM.NKR cells were prepared for single-cell RNA sequencing using the Chromium 
Single-Cell 5′ Reagent version 2 kit and Chromium Single-Cell Controller (10x Genomics, CA)49. Approximately 
2000–8000 cells per reaction suspended at a density of 50–500 cells/μL in PBS plus 0.5% FBS were loaded for gel 
bead-in-emulsion (GEM) generation and barcoding. Reverse transcription, RT-cleanup, and cDNA amplification 
were performed to isolate and amplify cDNA for downstream 5′ gene or enriched V(D)J library construction 
according to the manufacturer’s protocol. Libraries were constructed using the Chromium Single-Cell 5′ rea-
gent kit, 5′ Library Construction Kit, and i7 Multiplex Kit (10× Genomics, CA) according to the manufacturer’s 
protocol.
Sequencing. scRNAseq 5′ gene expression libraries were sequenced on an Illumina NovaSeq. 6000 instru-
ment using the S1, S2, or S4 reagent kits (300 cycles). Libraries were balanced to allow for ~150,000 reads/cell for 
5′ gene expression libraries. Sequencing parameters were set for 150 cycles for Read1, 8 cycles for Index1, and 
150 cycles for Read2. Prior to sequencing, library quality and concentration were assessed using an Agilent 4200 
TapeStation with High Sensitivity D5000 ScreenTape Assay and Qubit Fluorometer (Thermo Fisher Scientific) 
with dsDNA BR assay kit according to the manufacturer’s recommendations
5’ host gene expression analysis/visualization. 5′ gene expression alignment from in vitro infected 
DC-SIGN expressing CEM.NKR cells or sorted PBMC was performed using the 10x Genomics Cell Ranger 
pipeline49. Sample demultiplexing, alignment, barcode/UMI filtering, and duplicate compression was per-
formed using the Cell Ranger software package (10× Genomics, CA, v2.1.0, https://support.10xgenomics.com/
single-cell-gene-expression) and bcl2fastq2 (Illumina, CA, v2.20, https://support.illumina.com/downloads/bcl-
2fastq-conversion-software-v2-20.html) according to the manufacturer’s recommendations, using the default set-
tings and mkfastq/count commands, respectively. Transcript alignment was performed against a human reference 
library generated using the Cell Ranger mkref command and the Ensembl GRCh38 v87 top-level genome FASTA 
and the corresponding Ensembl v87 gene GTF. Multi-sample integration, data normalization, visualization, and 
differential gene expression was performed using the R package Seurat (v3.0, https://satijalab.org/seurat)50,51.
5’ DENV-1 genome analysis. Quantification and alignment of cell-associated DENV-1 genomic RNA 
from was performed using the 10x Genomics Cell Ranger pipeline49. Sample demultiplexing, alignment, barcode/
UMI filtering, and duplicate compression was performed using the Cell Ranger software package (10× Genomics, 
CA, v2.1.0, https://support.10xgenomics.com/single-cell-gene-expression) and bcl2fastq2 (Illumina, CA, v2.20, 
https://support.illumina.com/downloads/bcl2fastq-conversion-software-v2-20.html) according to the manu-
facturer’s recommendations, using the default settings and mkfastq/count commands, respectively. Transcript 
alignment was performed against a custom DENV-1 reference library generated using the Cell Ranger mkref 
command and the DENV-1 (strain Westpac74) FASTA and the corresponding gene GTF, or a custom DENV-1 
FASTA generated from targeted NGS analysis of contemporaneous serum samples from the individual analyzed 
in the study.
Cell associated DENV UMI dependent genomic visualization. DENV-1 mapped reads were pro-
vided in BAM format from the Cell Ranger pipeline. UMI-tools dedup was used to deduplicate the BAM files on 
a per cell basis using cell barcode, UMI barcode, and alignment position of the paired end reads (https://github.
com/CGATOxford/UMI-tools)52. BAM files were split into positive-sense and negative-sense mapped reads 
using BAM alignment tags provided by the Cellranger pipeline. Only read pairs where both reads mapped to 
the same genomic orientation were utilized in downstream visualizations. Using a list of cell barcodes identified 
as being associated with an intact cell by the cellranger count analysis of GRCh38 aligned transcripts, cell and 
unique UMI specific statistics were extracted using an in-house pipeline. In short, the BAM files were subset by 
cell barcode using 10x Genomics subset-bam (https://github.com/10XGenomics/subset-bam) followed conver-
sion to fastq using bedtools bamToFastq (https://github.com/arq5x/bedtools2)53. The reads were then remapped 
using BWA-MEM (https://github.com/lh3/bwa) and the BWA produced BAM files were analyzed using a custom 
Python script with a samtools (http://www.htslib.org)54 depth frontend. Unique UMI codes were extracted from 
the subset cell BAM and used to further subset the individual cell BAMs. The unique UMI assemblies were then 
analyzed similarly for assembly and coverage statistics. DENV-1 (strain Westpac74) was used as a reference for 
the in vitro samples and the constructed serum consensus was used for the natural infection samples.
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In addition to statistical files the pipeline outputs pickled python dictionaries with cell barcode or UMI keys 
and list values (with length of the reference genome) of genome depth of coverage. These dictionaries were used 
in the heatmap visualization of DENV-1 coverage. Individual cell coverage was ordered by percent coverage and 
the maximum heatmap intensity was set at a threshold three standard deviations above the mean. Unique UMIs 
were plotted for the top 10 cells in each in vitro sample. UMI were binned by cell and ordered by position in the 
DENV-1 genome. A low number of UMI outliers were removed with coverage at distant mapping locations on 
the DENV-1 genome.
DenV genomic assemblies. Viral RNA was extracted from serum using Qiagen Viral RNA Mini QIAcube 
kit (Qiagen Sciences, MD). Amplification was performed using 48 pairs of specific DENV-1 primers on the 
Fluidigm Access Array (Fluidigm Corporation, CA) with SuperScript III One-Step RT-PCR utilizing Platinum 
Taq High Fidelity polymerase (Thermo Fisher Scientific, MA). NGS libraries were prepared with QIAseq FX 
DNA Library Kit and sequenced on a Miseq with a v3 600 cycle sequencing kit. The sample reads were mapped 
to a DENV-1 Thailand strain (HM469967) using the NGS-mapper pipeline, that employs read quality filtering, 
trimming, mapping with BWA-MEM, and outputs assembly statistics and visualization for base call verification 
(https://github.com/VDBWRAIR/ngs_mapper)55. A minimum base quality threshold of 30.0 was used for base 
calling and variants were analyzed down to a 1% allele frequency threshold. Using NGS-mapper files, the consen-
sus sequences were manually curated for accuracy.
The constructed consensus DENV-1 genomes from the serum samples were used as a reference in the cell-
ranger pipeline. The resulting DENV-1 mapped BAM file, in conjunction with the cell barcodes obtained from 
cellranger count were used with 10× Geneomics subset-bam to exclude all reads not belonging to viable cells. 
Reads from the cell only BAM files were extracted using bedtools bamToFastq, and UMI-tools dedup was used 
to deduplicate UMIs. Optical duplicates were removed using BBMap clumpify (https://github.com/BioInfoTools/
BBMap) and the reads were remapped with NGS-mapper using the serum genomes as reference and manually 
curated. A minimum base quality threshold of 25.0 was used for base calling and a 10% threshold was used for 
reporting all cell-associated genomic variants.
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